SCHEMBL5577083

SCHEMBL5577083

NCCOCC(O)C(c1ccccc1)(c1ccccc1)c1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 3/20 0.41
KIF11 P52732 5/20 0.38
HTR2A P28223 2/20 0.35
HTR2C P28335 2/20 0.35
OPRK1 P41145 2/20 0.35
KCNH2 Q12809 2/20 0.35
ADRA1A P35348 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.32
KCNA3 P22001 2/20 0.31
TTR P02766 1/20 0.31
TAAR1 Q96RJ0 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
SLC22A1 O15245 1/20 0.30
NR1I2 O75469 1/20 0.30
GMNN O75496 1/20 0.30
USP2 O75604 1/20 0.30
TRPM2 O94759 1/20 0.30
ABCB11 O95342 1/20 0.30
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2406097 0.81 KCNN4 (0.46) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL2405440 0.79 KCNN4 (0.44) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL30513670 0.69 KMT2A (0.38) HTR2AOPRK1KCNH2ADRA1ASMN1; SMN2
SCHEMBL2821675 0.69 KMT2A (0.38) HTR2AOPRK1KCNH2ADRA1ASMN1; SMN2
SCHEMBL16416723 0.69 KCNN4 (0.45) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL27824023 0.67 KCNN4 (0.53) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL1701240 0.66 KCNN4 (0.53) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL5967507 0.66 KCNN4 (0.49) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL15069851 0.66 KIF11 (0.50) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL3238217 0.65 ALDH1A1 (0.43) ADRA1ASMN1; SMN2KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105759-A1 Melanocortin receptor 4 (mc4) agonists and their uses ELI LILLY AND COMPANY (US) 2007-05-10 US disclosed
EP-1644023-A2 MELANOCORTIN RECPTOR 4(MC4) AGONISTS AND THEIR USES ELI LILLY AND COMPANY (US) 2006-04-12 EP disclosed
WO-2005000339-A2 MELANOCORTIN RECEPTOR 4(MC4) AGONISTS AND THEIR USES ELI LILLY AND COMPANY (US) 2005-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105759-A1 Melanocortin receptor 4 (mc4) agonists and their uses MC4R, MC3R, MC1R KCNN4 685/4885KIF11 3801/4885HTR2A 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.